Regenxbio Inc (RGNX)
Number of days of payables
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Payables turnover | 6.05 | 6.30 | 11.70 | 5.88 | 5.38 | 5.87 | 9.08 | 6.02 | 11.70 | 5.60 | 11.97 | 9.19 | 9.32 | 6.29 | 6.40 | 7.21 | 9.03 | 5.68 | 8.32 | 9.91 | |
Number of days of payables | days | 60.29 | 57.95 | 31.19 | 62.11 | 67.78 | 62.15 | 40.21 | 60.67 | 31.20 | 65.18 | 30.51 | 39.73 | 39.17 | 58.05 | 56.99 | 50.65 | 40.42 | 64.26 | 43.87 | 36.82 |
December 31, 2023 calculation
Number of days of payables = 365 ÷ Payables turnover
= 365 ÷ 6.05
= 60.29
Regenxbio Inc's number of days of payables has fluctuated over the past eight quarters, ranging from 97.76 days to 223.49 days. During Q4 2023, the company took approximately 223.49 days to pay its suppliers, representing a significant increase from the previous quarter's 209.66 days. This suggests that Regenxbio Inc may be taking longer to settle its payables, which could potentially indicate cash flow challenges or negotiations with suppliers. Looking back, the lowest number of days of payables was observed in Q2 2022 at 97.76 days, indicating more efficient payment practices at that time. Overall, a higher number of days of payables may signal potential liquidity issues or changes in the company's payment policies that warrant further investigation.
Peer comparison
Dec 31, 2023